Thrombocytopenia treatment in Israel — get 3 personalized clinic matches

Consultation cost available upon request.

• Doctor details and specialization are being confirmed.
• Additional information about credentials and experience is being compiled.
• Please check back for a more detailed profile soon.

Dr. El Hasid has conducted over 300 bone marrow and umbilical blood transplantations at Dana Dwek Children's Hospital. She heads the Pediatric Oncohematology and Oncology department there.

• Specializes in bone marrow and umbilical blood transplantation specifically for children
• Trained at the prestigious City of Hope Hospital in Los Angeles
• Author of more than 50 scientific publications and 40 conference reports
• Member of the American Association for Hematology and Israeli Society for Pediatric Hematooncology

Dr. Ram has performed several hundred stem cell transplants for blood disorders like thrombocytopenia at Sourasky Medical Center (Ichilov). He is triple board-certified in Internal Medicine, Hematology, and Medical Oncology.

• Fellowship-trained in Hematology and Oncology at New York Medical College
• Published over 30 scientific articles on blood diseases and oncology
• Authored a chapter in a medical textbook
• Residency completed at the State University of New York at Brooklyn

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.